Skip to main content

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
BlackRock Inc. KIDS Orthopediatrics Corp 13G 5.1% 2y
BlackRock Inc. NDAQ Nasdaq, Inc. 13G 5.2% 2y
Migdal Insurance & Financial Holdings Ltd. ORA Ormat Technologies, Inc. 13G 6.36% 2y
Tetragon Financial Group Limited AUTL Autolus Therapeutics plc 13G/A 4.6% 2y
BlackRock Inc. KRTX Karuna Therapeutics, Inc. Common Stock 13G 5.3% 2y
Prescott Group Capital Management, L.L.C. CVEO Civeo Corp 13G/A 4.9% 2y
BlackRock Inc. COFS Choiceone Financial Services Inc 13G 5.4% 2y
BlackRock Inc. MHK Mohawk Industries Inc 13G/A 5.2% 2y
Migdal Insurance & Financial Holdings Ltd. NVMI Nova Ltd. 13G 6.6% 2y
BlackRock Inc. POWW Outdoor Holding Co 13G 5.3% 2y
Claret Asset Management Corp NOA North American Construction Group Ltd. 13G/A 7.52% 2y
Jonathan Klesch GFR Greenfire Resources Ltd. 13G 8.6% 2y
BlackRock Inc. TNYA Tenaya Therapeutics, Inc. 13G 5.6% 2y
Robert Bahr Logan GFR Greenfire Resources Ltd. 13G 7.3% 2y
Bulldog Investors, LLP KTF Dws Municipal Income Trust 13G 5.08% 2y
BlackRock Inc. FRBK Republic First Bancorp Inc 13G/A 5% 2y
Magnetar Financial LLC OKLO Oklo Inc. 13G/A 5.41% 2y
BlackRock Inc. FMAO Farmers & Merchants Bancorp Inc 13G/A 6.7% 2y
BlackRock Inc. BFIN BankFinancial Corporation 13G/A 5.4% 2y
BlackRock Inc. SVRA Savara Inc 13G 5.4% 2y
PICTET ASSET MANAGEMENT SA FIVN Five9, Inc. 13G 6.2% 2y
PICTET ASSET MANAGEMENT SA TTEK Tetra Tech Inc 13G 5.2% 2y
PICTET ASSET MANAGEMENT SA ALTR Altair Engineering Inc. Class A Common Stock 13G 5.3% 2y
SCLX Stock Acquisition JV LLC SCLX Scilex Holding Co 13D/A 38.2% 2y
Waratah Capital Advisors Ltd. ATLX Atlas Lithium Corp 13G 6.16% 2y
Julian Alexander McIntyre ARQ Arq, Inc. 13D/A 11.35% 2y
EcoR1 Capital, LLC ADAPY Adaptimmune Therapeutics PLC 13G 7.7% 2y
of Reporting Person: Eugene W. Landy S.S. # On File UMH Umh Properties, Inc. 13D/A 1.89% 2y
John D. Gottwald TG Tredegar Corp 13D/A 20.7% 2y
Jun Zhu NCTY The9 LTD 13D/A 18.6% 2y
Warren B. Kanders CLAR Clarus Corp 13D/A 16.7% 2y
Focused Compounding Fund, LP PRKA Parks America, Inc 13D/A 38.5% 2y
Yoda PLC CCEC Capital Clean Energy Carriers Corp. 13D/A 24.7% 2y
Établissements Peugeot Frères S.A. STLA Stellantis N.V. 13D/A 7.1% 2y
Leviticus Partners LP FRSX Foresight Autonomous Holdings Ltd. 13G/A 7.09% 2y
Cannae Holdings, Inc. PSFE Paysafe Ltd 13D/A 5.5% 2y
Albion River Management LLC DCO Ducommun Inc 13G 5.3% 2y
F. Hurst Lin (“Lin”) AUGX Augmedix, Inc. Common Stock 13D/A 6.8% 2y
Rosalind Advisors, Inc. SPRB Spruce Biosciences, Inc. 13G 5.67% 2y
Jeffrey Harris SBIG SBIG Holdings, Inc. 13D/A 17.4% 2y
VIKING GLOBAL INVESTORS LP ORIC Oric Pharmaceuticals, Inc. 13G 5.9% 2y
JWM Family Enterprises, Inc. MAR Marriott International Inc 13D/A 11.7% 2y
WCM INVESTMENT MANAGEMENT, LLC STE STERIS plc 13G/A 4.9% 2y
STATE STREET CORP FE Firstenergy Corp 13G/A 7.19% 2y
STATE STREET CORP AAT American Assets Trust, Inc. 13G/A 5.19% 2y
STATE STREET CORP ROIC Retail Opportunity Investments Corp. 13G/A 6.4% 2y
STATE STREET CORP ALEX Alexander & Baldwin, Inc. 13G/A 5.79% 2y
STATE STREET CORP JBGS JBG SMITH Properties 13G/A 6.62% 2y
River Road Asset Management, LLC EMBC Embecta Corp. 13G 5.8% 2y
Franklin Mutual Advisers, LLC GBX Greenbrier Companies Inc 13G/A 0% 2y